tiprankstipranks
Trending News
More News >
Haemonetics Earnings Call: Growth Amid Challenges
PremiumCompany AnnouncementsHaemonetics Earnings Call: Growth Amid Challenges
3M ago
Haemonetics price target lowered to $115 from $120 at Raymond James
Premium
The Fly
Haemonetics price target lowered to $115 from $120 at Raymond James
3M ago
Haemonetics price target lowered to $90 from $115 at Mizuho
Premium
The Fly
Haemonetics price target lowered to $90 from $115 at Mizuho
3M ago
Haemonetics: Strong Margin Performance Justifies Buy Rating Despite Revenue Challenges
PremiumRatingsHaemonetics: Strong Margin Performance Justifies Buy Rating Despite Revenue Challenges
3M ago
Haemonetics narrows FY25 adjusted EPS view to $4.50-$4.70 from $4.45-$4.75
Premium
The Fly
Haemonetics narrows FY25 adjusted EPS view to $4.50-$4.70 from $4.45-$4.75
3M ago
Haemonetics reports Q3 adjusted EPS $1.19, consensus $1.17
Premium
The Fly
Haemonetics reports Q3 adjusted EPS $1.19, consensus $1.17
3M ago
Haemonetics to sell whole blood assets to GVS for $44.6M upfront
PremiumThe FlyHaemonetics to sell whole blood assets to GVS for $44.6M upfront
5M ago
Haemonetics management to meet virtually with BTIG
Premium
The Fly
Haemonetics management to meet virtually with BTIG
5M ago
Haemonetics management to meet virtually with BTIG
Premium
The Fly
Haemonetics management to meet virtually with BTIG
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100